
    
      Objective:

      This study was designed to determine, in a screening situation within the framework of
      university preventive medicine, the prevalence of positive anti-SARS-Cov 2 serology among the
      staff of the University of Reims Champagne-Ardenne. The serological tests chosen will allow
      systematic detection of anti-SARS-CoV-2 IgM and anti-SARS-Cov-2 IgG to assess the moment of
      potential contamination prior to resumption of occupational activity.

      Type of study:

      This is a prevalence study, a single-center cross-sectional study published on the human
      person.

      Population:

      Inclusion criteria: On a voluntary basis, the staff of the University of Reims Champagne
      Ardenne will be offered a serological blood test (1 dry tube of 7ml). The use of the
      collected data for research purposes will be explained to each requester, with signature of
      an informed consent. Only people over 18 will be included.

      Non-inclusion criteria: Staff of the University of Reims Champagne Ardenne who have not
      requested to be tested. Duration of participation of subjects: 1/2 day time

      Judgment criterion (s):

      Main endpoint (in connection with the main objective): Prevalence of positive SARS-CoV-2
      serology at the University of Reims Champagne-Ardenne.

      Clinical investigation plan:

        -  Phase 1: Communication strategy An email will be sent to all the staff of the University
           of Reims Champagne Ardenne to offer them anti-SARS-Cov-2 serological tests, as part of a
           health research protocol. Before sampling, a questionnaire will be completed by the
           applicant.

        -  Phase 2: Analysis of the samples

        -  Phase 3: Transmission of results to Pr Frédéric Deschamps, head of SUMMPS at the
           University of Reims Champagne Ardenne
    
  